SOURCE: Milestone Scientific, Inc.

Milestone Scientific, Inc.

February 26, 2015 08:30 ET

Milestone Scientific Appoints Dr. Edward Zelnick, MD to the Board of Directors

LIVINGSTON, NJ--(Marketwired - February 26, 2015) - Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that Dr. Edward Zelnick has been appointed to the Board of Directors.

Dr. Zelnick's career in the medical field spans over forty years. From 1972 to 2000, Dr. Zelnick was a physician and surgeon specializing in obstetrics and gynecology and had multi-year terms as Chief of Department Ob-Gyn at Hollywood Medical Center, Memorial Regional Hospital and Memorial Hospital West. In 2000, Dr. Zelnick co-founded Horizon Institute for Clinical Research where he held the position of Chief Executive Officer. The institute provided central trial organization and recruitment for clinical research organizations and pharmaceutical companies from 2000 to 2011. Dr. Zelnick has participated in numerous clinical research studies in diverse fields including cardiology, dermatology, endocrinology, gastroenterology, ophthalmology and gynecology, among others.

Leonard Osser, Chief Executive Officer of Milestone Scientific, commented, "Dr. Zelnick's expertise as a doctor as well as a researcher across a broad spectrum of clinical studies makes him a valuable resource to us as we assess and prioritize the multitude of potential applications for our computer-controlled injection technology in the medical arena. As a physician specializing in obstetrics and gynecology, Dr. Zelnick has an appreciation for the importance of the epidural instrument that we have developed, which will be introduced in Europe this year. The epidural and intra-articular medical instruments have now both received CE Mark marketing clearance in Europe and we are making progress towards FDA marketing clearance in the U.S. We welcome Dr. Zelnick to the board of directors and look forward to his contributions."

About Milestone Scientific Inc.

Milestone Scientific Inc. is a leading medical research and development company that designs and patents innovative injection technology. Milestone's computer-controlled systems make injections precise, efficient, and virtually painless. For more information please visit our website: www.milestonescientific.com

Safe Harbor Statement
This press release contains forward-looking statements regarding the timing and financial impact of Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report for the year ended December 31, 2013. The forward looking-statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

Contact Information

  • Contact:
    David Waldman or Klea Theoharis
    Crescendo Communications, LLC
    Email: mlss@crescendo-ir.com
    Tel: 212-671-1020